Related Experiment Videos

Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes

Scott D Kobayashi1, Jovanka M Voyich, Kevin R Braughton

  • 1Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.

Insights

Polymorphonuclear leukocytes (PMNs) reduce inflammation by down-regulating key genes during apoptosis. This study reveals molecular mechanisms for inflammation resolution in humans.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Polymorphonuclear leukocytes (PMNs) are crucial for innate immunity and inflammation.
  • The molecular mechanisms terminating inflammation in humans are not fully understood.

Purpose of the Study:

  • To identify genes regulated during apoptosis-induced inflammation resolution.
  • To elucidate the molecular basis for the termination of inflammation by PMNs.

Main Methods:

  • Human oligonucleotide microarrays were used to analyze gene expression during PMN apoptosis.
  • Flow cytometry was employed to validate gene expression changes.

Main Results:

  • 133 of 212 differentially expressed genes involved in inflammation were down-regulated during PMN apoptosis.
  • Key inflammatory mediators, receptors, and signal transduction components showed reduced expression.
  • Down-regulation of IL-8R beta (CXCR2) and IL-1 alpha was confirmed via flow cytometry.

Conclusions:

  • PMNs actively decrease their proinflammatory capacity at the gene expression level during apoptosis.
  • This study provides novel insights into the molecular events resolving inflammation post-PMN activation.

Related Concept Videos